Scientific Program

The scientific program for the 2023 ESVONC congress in Alicante is ready. 

There will be no live streaming this year.  

The Nurses program on Friday 26th & Saturday 27th May is visible under the separate tab in the top menu.



The Meliá Alicante Hotel will be the venue for the 2023 ESVONC Congress.


Wednesday 24th May - Residents' Workshop

Residents' Workshop on Scientific Writing
15.00-15.45 Study design part 1 - kindly sponsored by Craig Clifford
15.45-16.30 Study design part 2 - kindly sponsored by Craig Clifford
16.30-17.00 COFFEE BREAK  
17.00-17.45 Scientific writing: Reasons for Manuscript Rejections Dan Chan
17.45-18.15 Scientific writing: Structuring a Scientific Paper Dan Chan


Thursday 25th May - Main program

08.45-09.00 Welcome ESVONC to Alicante! P. Clemente & J. Borrego
Themed Session: Nutrition & Cancer
09.00-09.45 Recent developments in nutritional modulation of neoplastic processes Dan Chan
09.45-10.30 Scope for clinical applications of nutritional interventions for the oncological patient Dan Chan
10.30-11.00 COFFEE BREAK – kindly sponsored by        
11.00-11.45 The Role of the Gut Microbiome in Cancer Carolina Cortes
11.45-12.30 Modulating the Gut Microbiome: Researching Nutritional Approaches Carolina Cortes
12.30 - 13.00 PANEL DISCUSSION  
13.00-14.30 Lunch & Poster Session  

Nutritional Support for Pets with Cancer: a New Option


Becky Mullis
Resident Abstracts
15.00-15.15 Safety and tolerability assessment of a combined protocol including lomustine, vincristine and prednisolone in cats with lymphoma  Sergio Vázquez Martínez
15.15-15.30 Feline high-grade alimentary lymphomas treated with COP or CHOP-based chemotherapy: a multicentric retrospective study of 57 cases Grégoire Bernardo Marques 
15.30-15.45 A multi-institutional comparative study of (L)COP/CHOP based chemotherapy with and without abdominal radiotherapy for feline gastrointestinal high grade lymphoma in 26 cats Andrea Rey
15.45-16.00 First in dog: clinical remissions in dogs with diffuse large B-cell lymphoma (DLBCL) after radioimmunotherapy (RIT) using a murine anti-canine-CD22 monoclonal antibody Catherine Ibisch
16.00-16.30 COFFEE BREAK – kindly sponsored by       
General Abstracts
16.30-16.45 Association of allergic skin disease with the development of canine mast cell tumours (MCT): is a pruritic dog more prone to develop severe MCT? Marianne Lappalainen
16.45-17.00 Retrospective analysis investigating the independence of histological and immunohistochemical prognostic factors from 199 canine mast cell tumours with follow up from their primary care practices Katherine Boyd
17.00-17.15 Immunohistochemistry expression of immune checkpoint molecules PD-L1 and CTLA-4 in canine mast cell tumors Mariana Ribeiro 
17.15-17.30 Post-FDA approval analysis of Stelfonta® (tigilanol tiglate) use by veterinary oncologists for canine mast cell tumors Pamela Jones


Presentation of the Fund and Approved Projects

ESVONC CRF Committee

Welcome Reception in Alicante!

venue: Museo The Ocean Race

kindly sponsored by




Friday 26th May - Main Program

Themed Session: Things I used to do but stopped and things I didn't do but started!
09.00-09.20 Lymph node mapping Vincent Wavreille
09.20-09.40 Caudal maxillectomy Nick Bacon
09.40-10.00 Insulinomas Vincent Wavreille
10.00-10.30 COFFEE BREAK – kindly sponsored by      
10.30-10.50 Bilateral adrenalectomies Nick Bacon
10.50-11.10 Liver tumours Vincent Wavreille
11.10-11.30 Amputation Nick Bacon
11.30-12.15 PANEL DISCUSSION  
12.15-14.30 Lunch  
Resident Abstracts
14.30-14.45 Comparison of lymphoscintigraphy and near-infrared fluorescence lymphography for sentinel lymph node biopsy in dogs with integumentary mast cell tumors Lavinia Elena Chiti
14.45-15.00 Near-infrared lymphography versus CT-Lymphography for primary lymph node detection in dogs with ASAC – a case series Mirja Nolff
15.00-15.15 Weishaar’s classification system for nodal metastasis in sentinel lymph nodes: update on clinical outcome in 94 dogs with mast cell tumor Elisa Maria Gariboldi
15.15-15.30 Clinical presentation and prognostic factors in 32 dogs with subcutaneous mast cell tumors treated with curative intent surgery Xavier Escoda Llorens
15.30-16.00 COFFEE BREAK – kindly sponsored by      

Elevating Oncology Diagnosis with the Virtual Experience


Lucia Carranza
General Abstracts
16.30-16.45 Grading radiation toxicity after chemoradiotherapy of canine urinary tract carcinomas with VRTOG_v2.0  Carlotta Ahrens
16.45-17.00 Adjuvant dose-intensified doxorubicin protocol for splenic canine hemangiosarcoma: a pilot study Miguel Garcia de la Virgen
17.00-17.15 Cytokines might tell us something - IL-12/IL-23p40 and IL-12 in Nova Scotia Duck Tolling Retrievers with cancer and autoimmune disease  Malin Nilsson 
17.15-17.30 Plasma H3.1 nucleosome concentrations in dogs with various carcinomas Heather Wilson-Robles
18.00-... Evening on your own!  


Saturday 27th May - Main Program

Themed Session: Liquid biopsy
09.00-09.45 Liquid Biopsies in Diagnostic Pathology: A Brief History and Current and Future Applications Jaime Modiano
09.45-10.30 Liquid biopsy in (human) oncology: clinical applications Aitor Azkarate
10.30-11.00 COFFEE BREAK – kindly sponsored by      
11.00-11.45 A Liquid Biopsy Platform for Novel Exosome-Based Cancer Diagnostics and Its Applications in Medicine and Veterinary Medicine Jaime Modiano
11.45-12.30 Defining the Cancer Permissive Environment and Its Applications in Early Detection, Risk Assessment, and Strategic Prevention of Cancer Jaime Modiano
12.30-13.00 PANEL DISCUSSION  
13.00-14.30 Lunch  

The Use of OncoK9 Liquid Biopsy in Specialty Practice


Andy Flory
Resident Abstracts
15.30-15.45 Evaluation of a novel liquid biopsy-based assay for cancer detection and monitoring in dogs  Suzanne Busser 
15.45-16.00 Clinico-genomics analysis of 94 canine mammary tumors as an opportunity for targeted therapy Lucas Rodrigues
16.00-16.15 Update World Meeting Tokyo 2024 Tetsuya Kobayashi
16.15-16.45 COFFEE BREAK – kindly sponsored by      

It all started over a cup of coffee (the VCS experience)

Sandi Strother (VCS Director)
General Abstracts
17.15-17.30 Proteomic profiling of feline fibrosarcoma and its adjacent peritumoral tissue  Enni Markkanen
17.30-17.45 Molecular characterization of canine FSA using spatially defined transcriptomics and proteomics  Daniel Fuchs
17.45-18.00 Fibroblast activation protein - a promising target for canine, feline and human soft tissue sarcoma Patricia Beer


venue: Castillo de Santa Bárbara

kindly sponsored by